Health And Biotech Startups Now Get The Majority Of US Series A Funding

Health And Biotech Startups Now Get The Majority Of US Series A Funding

Source: 
Crunchbase
News Tags: 
snippet: 

This year is shaping up as the first we’ve seen in which biotech and healthcare startups receive a majority of U.S. Series A commitments.

So far in 2024, biotech and health companies have pulled in around $5.6 billion across 110 Series A rounds, per Crunchbase data. That accounts for 53% of all funding at the Series A stage, which is a closely watched barometer for the startup ecosystem.